Skip to main content

AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) Investor Securities Class Action Lawsuit 06/08/2021

  • If you purchased shares of AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

March 7, 2022 - An amended complaint was filed. June 8, 2021 - An investor in shares of AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) filed a lawsuit in the U.S. District Court for the Northern District of California over alleged violations of Federal Securities Laws by AcelRx Pharmaceuticals, Inc. in connection with certain allegedly false and misleading statements made between March 1...

You must register (for free) or login to view the entire case.